HRP970239B1 - Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity - Google Patents

Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity

Info

Publication number
HRP970239B1
HRP970239B1 HR970239A HRP970239A HRP970239B1 HR P970239 B1 HRP970239 B1 HR P970239B1 HR 970239 A HR970239 A HR 970239A HR P970239 A HRP970239 A HR P970239A HR P970239 B1 HRP970239 B1 HR P970239B1
Authority
HR
Croatia
Prior art keywords
sulfonyl
preparation
antitumor activity
pyrimidine derivatives
derivatives
Prior art date
Application number
HR970239A
Other languages
English (en)
Inventor
Biserka Kauenar
Mladen Aeinic
Irena Krizmanic
Original Assignee
Inst Ru Er Bouekovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Ru Er Bouekovic filed Critical Inst Ru Er Bouekovic
Priority to HR970239A priority Critical patent/HRP970239B1/xx
Priority to EP98108370A priority patent/EP0877022B1/fr
Priority to CZ981424A priority patent/CZ142498A3/cs
Priority to DE69813362T priority patent/DE69813362T2/de
Priority to AT98108370T priority patent/ATE237594T1/de
Priority to CA002237267A priority patent/CA2237267A1/fr
Priority to PL98326236A priority patent/PL326236A1/xx
Publication of HRP970239A2 publication Critical patent/HRP970239A2/hr
Publication of HRP970239B1 publication Critical patent/HRP970239B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR970239A 1997-05-09 1997-05-09 Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity HRP970239B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
HR970239A HRP970239B1 (en) 1997-05-09 1997-05-09 Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity
EP98108370A EP0877022B1 (fr) 1997-05-09 1998-05-07 Dérivés de sulfonylpyrimidine avec une action antitumorale
CZ981424A CZ142498A3 (cs) 1997-05-09 1998-05-07 Syntéza derivátů sulfonylpyrimidinu s protirakovinným účinkem
DE69813362T DE69813362T2 (de) 1997-05-09 1998-05-07 Sulfonylpyrimidine Derivate mit Antitumor Wirkung
AT98108370T ATE237594T1 (de) 1997-05-09 1998-05-07 Sulfonylpyrimidine derivate mit antitumor wirkung
CA002237267A CA2237267A1 (fr) 1997-05-09 1998-05-08 Synthese de derives de la sulfonylpyrimidine possedant une activite anticancer
PL98326236A PL326236A1 (en) 1997-05-09 1998-05-11 Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR970239A HRP970239B1 (en) 1997-05-09 1997-05-09 Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity

Publications (2)

Publication Number Publication Date
HRP970239A2 HRP970239A2 (en) 1999-02-28
HRP970239B1 true HRP970239B1 (en) 2004-04-30

Family

ID=10946575

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970239A HRP970239B1 (en) 1997-05-09 1997-05-09 Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity

Country Status (7)

Country Link
EP (1) EP0877022B1 (fr)
AT (1) ATE237594T1 (fr)
CA (1) CA2237267A1 (fr)
CZ (1) CZ142498A3 (fr)
DE (1) DE69813362T2 (fr)
HR (1) HRP970239B1 (fr)
PL (1) PL326236A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE325104T1 (de) * 1998-03-30 2006-06-15 Hoffmann La Roche Verfahren zu fabrikation von alpha 1l- adrenorezeptor antagonisten
JP5749017B2 (ja) 2008-01-22 2015-07-15 ダウ アグロサイエンシィズ エルエルシー ５−フルオロピリミジン誘導体
UA106889C2 (uk) 2009-08-07 2014-10-27 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні n1-ацил-5-фторпіримідинону
PT2462134E (pt) * 2009-08-07 2014-07-28 Dow Agrosciences Llc Derivados de n1-sulfonil-5-fluoropirimidinona
UA107671C2 (en) 2009-08-07 2015-02-10 Dow Agrosciences Llc N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
UA112284C2 (uk) 2009-08-07 2016-08-25 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні 5-фторпіримідинону
EP2521452B1 (fr) 2010-01-07 2014-12-24 Dow AgroSciences LLC THIAZOLO[5,4-d]PYRIMIDINES ET LEUR UTILISATION EN TANT QUE PRODUITS AGROCHIMIQUES
LT2563129T (lt) * 2010-04-26 2016-10-25 Adama Makhteshim Ltd N3-pakeisti-n1-sulfonil-5-fluorpirimidinono dariniai
RU2613451C2 (ru) 2011-08-17 2017-03-16 Адама Мактешим Лтд. Производные 5-фтор-4-имино-3-(замещенного)-3, 4-дигидропиримидин-2(1н)она, композиция на их основе и спсоб борьбы с грибковыми заболеваниями
CA2893778A1 (fr) 2012-12-28 2014-07-03 Dow Agrosciences Llc Derives carboxylates de n-(substitue)-5-fluoro-4-imino-3-methyle-2-oxo-3,4-dihydropyrimidine-1 (2h)-
CN104994859B (zh) 2012-12-28 2018-10-26 阿达玛马克西姆股份有限公司 1-(取代的苯甲酰基)-5-氟-4-亚氨基-3-甲基-3,4-二氢嘧啶-2(1h)-酮衍生物
JP6258969B2 (ja) 2012-12-28 2018-01-10 アダマ・マクテシム・リミテッド Ｎ−（置換）−５−フルオロ−４−イミノ−３−メチル−２−オキソ−３，４−ジヒドロピリミジン−１（２ｈ）−カルボキサミド誘導体
AU2013370494B2 (en) 2012-12-31 2017-08-17 Adama Makhteshim Ltd. 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1H)-one derivatives as fungicides
BR112016015158A2 (pt) 2013-12-31 2017-08-08 Adama Makhteshim Ltd Misturas fungicidas sinergísticas para controle de fungos em cereais
CA2935601C (fr) 2013-12-31 2023-03-14 Adama Makhteshim Ltd. 5-fluoro-4-imino-3-(alkyle/alkyle substitue)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one et procedes pour leur preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324952B2 (fr) * 1973-11-28 1978-07-24
JPS51105080A (en) * 1975-03-07 1976-09-17 Mitsui Seiyaku Kogyo Kk 55 furuororashirujudotainoseizohoho
AU523746B2 (en) * 1977-04-05 1982-08-12 Taiho Pharmaceutical Co., Ltd. Anticancer composition
JPS5587777A (en) * 1978-12-27 1980-07-02 Ono Pharmaceut Co Ltd Pyrimidine derivative, its preparation and antitumorigenic agent
JPS6293281A (ja) * 1985-10-17 1987-04-28 Kyowa Hakko Kogyo Co Ltd 抗腫瘍剤

Also Published As

Publication number Publication date
CZ142498A3 (cs) 1999-08-11
ATE237594T1 (de) 2003-05-15
DE69813362D1 (de) 2003-05-22
CA2237267A1 (fr) 1998-11-09
DE69813362T2 (de) 2004-04-01
PL326236A1 (en) 1998-11-23
EP0877022A1 (fr) 1998-11-11
EP0877022B1 (fr) 2003-04-16
HRP970239A2 (en) 1999-02-28

Similar Documents

Publication Publication Date Title
HRP970239B1 (en) Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity
NZ304859A (en) 4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives, medicaments and processes for the preparation thereof
MX9800215A (es) Pirrolopirimidas y procesos para su preparacion.
CA2388140A1 (fr) Heterocycles d'azote bicyclique substitues par de l'alkylamino en tant qu'inhibiteurs de proteine kinase p38
AU6194994A (en) Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
AU6194794A (en) Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
HUT52769A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions containing them
IL117923A (en) Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
DE69710490T2 (de) Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
CA2311922A1 (fr) Thienopyrimidines
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ATE119157T1 (de) Pyrimidinderivate zur erhöhung der antitumoraktivität.
BR9814543A (pt) " derivados 3'-epiméricos de k-252a "
ES2105959A1 (es) Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.
GR852525B (fr)
AU6278700A (en) 1,2-dihydro-1-oxo-pyrazino[1,2-a]indole derivatives
AU2334188A (en) 5-oxo-imidazo-(1,5-a)-thieno (2,3-e) pyrimidine derivatives
KR100344711B1 (fr)
WO2001000188A3 (fr) Derives de tetrahydrochinolinyl-6-methyldihydrothiadiazinone et leur utilisation
DE3778612D1 (de) Diaminopyrimido(4,5-d)pyrimidin-glycoside und -glycotide und verfahren.
AU578125B2 (en) Pyrazine diazohydroxide compounds
DE3875807D1 (de) 3-acylaminomethyl-5,6,7,8-tetrahydroimidazo(1,2-a)pyridinderivate, ihre herstellung und therapeutische verwendung.
EP0264951A3 (en) Procaterol-derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: INSTITUT RUDER BOSKOVIC, HR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20040408

Year of fee payment: 8

B1PR Patent granted
PPPP Transfer of rights

Owner name: BIOZYNE D.O.O., HR

PBON Lapse due to non-payment of renewal fee

Effective date: 20050510